#279 – AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins
“It is worth noting, and this is a very important question, that it does not appear that the effect of statins on insulin resistance is a function of lipids being lowered.” —Peter Attia
Are continuous glucose monitors a waste of time for people without diabetes?
Some experts suggest CGMs are useless for nondiabetics. I disagree.
#162 – Sarah Hallberg, D.O., M.S.: Challenging the status quo of treating metabolic disease, and a personal journey through a grim cancer diagnosis
“For a disease that everyone thought was chronic and progressive, to see people recover from it is quite astounding.” —Sarah Hallberg
#155 – Chris Sonnenday, M.D.: The history, challenges, and gift of organ transplantation
“Knowing that their loved one’s organs live on in another individual and saved their life is the only good thing about what was otherwise the worst day of their lives … I think it’s important for people to hear that it can be a transformative gift.” — Chris Sonnenday